Absence of QTc prolongation with betrixaban: a randomized, double-blind, placebo- and positive-controlled thorough ECG study

By Morganroth Joel   Gretler Daniel D   Hollenbach Stanley J   Lambing Joseph L   Sinha Uma  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 5-13

Informa Healthcare

Access to resources Recommend Favorite

Effect of Nalmefene 20 and 80 mg on the Corrected QT Interval and T-Wave Morphology: A Randomized, Double-Blind, Parallel-Group, Placebo- and Moxifloxacin-Controlled, Single-Centre Study

By Matz Jørgen  

Clinical Drug Investigation, Vol. 31, Iss. 11, 2011-11 ,pp. : 799-811

Adis International

Access to resources Recommend Favorite

Randomized, Blinded, Placebo‐ and Positive‐Controlled Crossover Study to Determine the Effect of Deferiprone on the QTc Interval in Healthy Subjects

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 1, 2018-01 ,pp. : 22-32

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of AZD0837, a Novel Direct Thrombin Inhibitor, on the Electrophysiological Properties of the Human Heart: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study

By Walfridsson Håkan  

Clinical Drug Investigation, Vol. 30, Iss. 7, 2010-07 ,pp. : 461-471

Adis International

Access to resources Recommend Favorite

Effects of Prulifloxacin on Cardiac Repolarization in Healthy Subjects: A Randomized, Crossover, Double-Blind versus Placebo, Moxifloxacin-Controlled Study

By >   >   Dionisio Paolo  

Clinical Drug Investigation, Vol. 30, Iss. 1, 2010-01 ,pp. : 5-14

Adis International

Access to resources Recommend Favorite